Lobbyist Public Search Mass. state house
Records prior to registration year 2005 are not available online.

Contact the Lobbyist Division here for assistance. 		Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
Your comments are welcome:  submit feedback
Disclosure reporting details
Back to search detail summary
Lobbyist Entity disclosure reporting period:   07/01/2025 - 12/31/2025
Authorizing Officer name John F.X. Heffernam
Title Principal
Business name Park Street Strategies, LLC
Address 121 Mount Vernon Street   
City, state, zip code Boston, MA 02108         
Country US
Phone 617-981-0015 

Client Compensation
NameAmount
Acuity Strategic Partners LLC $50,000.00
Amgen Inc. $36,000.00
NanoDx, Inc $0.00
Acadia Pharmaceuticals Inc. $30,000.00
Massachusetts Biotechnology Council, Inc $60,000.00
Sage Therapeutics, Inc. $33,000.00
UCB, Inc. $30,000.00
Biotechnology Innovation Organization $29,500.00
PTC Therapeutics $0.00
Total salaries received $268,500.00

 
Compensation/Salaries Paid
Lobbyist or Entity nameSalaries
John F.X. Heffernan $117,000.00
Total salaries paid $117,000.00
 
Activities, Bill Numbers and Titles
No activities, bill numbers or bill titles were disclosed for this reporting period.
 
Operating Expenses
DateRecipientType of expenseAmount
08/19/2025 Ward & Lawless LLC, compliance support services Other operating expenses $1,031.25
12/19/2025 Ward & Lawless LLC, compliance support services Other operating expenses $1,417.50
10/15/2025 Staples Photocopies, scans $270.34
12/23/2025 Apple Computer equipment, supplies $1,698.94
12/31/2025 Meeting House Office & Retail Internet fees $570.00
12/20/2025 Riley & Dever, PC Legal fees $670.00
07/22/2025 US Postal Service Postage, shipping, delivery $11.78
09/13/2025 UPS Postage, shipping, delivery $22.53
12/23/2025 Staples Office supplies, equipment $2,019.81
12/31/2025 Meeting House Office & Retail Rent $7,059.30
11/08/2025 State Affairs Professional subscriptions $3,500.00
12/31/2025 AT&T Telephone, cell phone, handheld $799.19
  Total operating expenses $19,070.64
 
Meals, Travel, and Entertainment Expenses
DateLobbyist nameEvent typePayee/VendorAttendeesAmount
07/25/2025Park Street Strategies, LLC Travel LAZ Parking, for parking John Heffernan $15.00
07/29/2025Park Street Strategies, LLC Travel MBTA Parking, for parking John Heffernan $14.00
07/30/2025Park Street Strategies, LLC Travel LAZ Parking, for parking John Heffernan $36.00
09/11/2025Park Street Strategies, LLC Travel VPNE Tech Square Parking, for parking John Heffernan $34.00
09/25/2025Park Street Strategies, LLC Travel MBTA Parking, for parking John Heffernan $7.00
10/15/2025Park Street Strategies, LLC Travel MBTA Parking, for parking John Heffernan $7.00
10/21/2025Park Street Strategies, LLC Travel One Kendall Parking, for parking John Heffernan $54.00
10/30/2025Park Street Strategies, LLC Travel MBTA Parking, for parking John Heffernan $7.00
11/08/2025Park Street Strategies, LLC Travel MBTA Parking, for parking John Heffernan $2.00
12/08/2025Park Street Strategies, LLC Travel MBTA Parking, for parking John Heffernan $7.00
    Total amount $183.00
 
Additional Expenses
No additional expenses were filed for this disclosure reporting period.
 
Campaign Contributions
No campaign contributions were filed for this disclosure reporting period.
 
Lobbyist: John F.X. Heffernan
Client: Massachusetts Biotechnology Council, Inc
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 1364 An Act relative to promoting healthcare access and affordability for patients Support $0.00 N/A
Senate Bill 724 An Act promoting healthcare access and affordability for patients Support $0.00 N/A
House Bill 1274 An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program Oppose $0.00 N/A
House Bill 4494 An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program Oppose $0.00 N/A
House Bill 1107 An Act prohibiting discrimination against 340b drug discount program participants Oppose $0.00 N/A
House Bill 4490 An Act prohibiting discrimination against 340b drug discount program participants Oppose $0.00 N/A
House Bill 1296 An Act to protect 340B providers Oppose $0.00 N/A
House Bill 4495 An Act to protect 340B providers Oppose $0.00 N/A
Senate Bill 819 An Act prohibiting discrimination against 340b drug discount program participants Oppose $0.00 N/A
Senate Bill 779 An Act to protect 340B providers Oppose $0.00 N/A
House Bill 785 An Act protecting 340B contract pharmacies Oppose $0.00 N/A
Senate Bill 845 An Act to protect 340B providers in the Medicaid program Oppose $0.00 N/A
House Bill 779 An Act to protect 340B providers in the MassHealth program Oppose $0.00 N/A
Senate Bill 868 An Act enhancing health care market oversight and pharmaceutical access Oppose $0.00 N/A
Senate Bill 848 An Act relating to covered entity reporting to increase accountability to safeguard benefit for vulnerable patients Neutral $0.00 N/A
House Bill 1082 An Act to enact the pharmacy benefit manager compensation reform Support $0.00 N/A
House Bill 1167 An Act to enact pharmacy benefit manager duties Support $0.00 N/A
House Bill 1334 An Act to enact pharmacy benefit manager duties Neutral $0.00 N/A
House Bill 1234 An Act relative to pharmacy benefit managers Support $0.00 N/A
House Bill 1324 An Act relative to prescription drug pricing Neutral $0.00 N/A
House Bill 1326 An Act to ensure access to prescription medications Neutral $0.00 N/A
House Bill 4346 An Act to ensure access to prescription medications Neutral $0.00 N/A
Senate Bill 827 An Act to ensure access to prescription medications Neutral $0.00 N/A
House Bill 1322 An Act ensuring access to specialty medications Neutral $0.00 N/A
House Bill 4497 An Act ensuring access to specialty medications Neutral $0.00 N/A
Senate Bill 734 An Act ensuring access to specialty medications Neutral $0.00 N/A
Senate Bill 694 An Act empowering health care consumers Neutral $0.00 N/A
House Bill 1325 An Act to ensure access to generic medication Neutral $0.00 N/A
Senate Bill 875 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
House Bill 1092 An Act to ensure affordable prescription medications through accountability standards Neutral $0.00 N/A
House Bill 4489 An Act to ensure affordable prescription medications through accountability standards Neutral $0.00 N/A
House Bill 1080 An Act relative to copay assistance Neutral $0.00 N/A
House Bill 4043 An Act relative to copay assistance for medications Neutral $0.00 N/A
House Bill 1101 An Act relative to consumer deductibles Support $0.00 N/A
House Bill 4333 An Act relative to consumer deductibles Support $0.00 N/A
Senate Bill 698 An Act relative to consumer deductibles Support $0.00 N/A
House Bill 1384 An Act updating the health care cost growth benchmark and associated market oversight activities Neutral $0.00 N/A
Senate Bill 1583 An Act to restore integrity in the marketing of pharmaceutical products and medical devices Neutral $0.00 N/A
Senate Bill 1584 An Act to prevent undue influence on prescriber behavior Neutral $0.00 N/A
Senate Bill 895 An Act to promote transparency and prevent price gouging of pharmaceutical drug prices Neutral $0.00 N/A
Senate Bill 884 An Act to define modest meals and refreshments in prescriber education settings Neutral $0.00 N/A
Senate Bill 2035 An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing Neutral $0.00 N/A
House Bill 2509 An Act relative to the availability of prescription medication during an emergency Neutral $0.00 N/A
Senate Bill 904 An Act to strengthen health spending accountability processes within the health policy commission and the center for health information and analysis Neutral $0.00 N/A
House Bill 1374 An Act establishing a state-wide drug repository program Neutral $0.00 N/A
House Bill 1227 An Act relative to patient access to biomarker testing to provide appropriate therapy Support $0.00 N/A
House Bill 4339 An Act relative to patient access to biomarker testing to provide appropriate therapy Support $0.00 N/A
Senate Bill 809 An Act relative to patient access to biomarker testing to provide appropriate therapy Support $0.00 N/A
House Bill 1368 An Act to provide rapid whole genome sequencing Support $0.00 N/A
Senate Bill 847 An Act relative to rapid whole genome sequencing Support $0.00 N/A
House Bill 2384 An Act relative to provider choice Support $0.00 N/A
Senate Bill 1514 An Act relative to provider choice Support $0.00 N/A
House Bill 1125 An Act relative to non-medical switching Neutral $0.00 N/A
House Bill 4491 An Act relative to non-medical switching Neutral $0.00 N/A
Senate Bill 693 An Act relative to non-medical switching Neutral $0.00 N/A
House Bill 1136 An Act improving the health insurance prior authorization process Neutral $0.00 N/A
House Bill 4616 An Act improving the health insurance prior authorization process Neutral $0.00 N/A
House Bill 4375 An Act to preserve and advance Massachusetts’ competitiveness in discovery, research, and innovation for a vibrant economy Support $0.00 N/A
House Bill 401 An Act to protect innovation and entrepreneurship in the Commonwealth Oppose $0.00 N/A
House Bill 2430 An Act including Krabbe Disease in newborn screening Neutral $0.00 N/A
Senate Bill 1530 An Act improving newborn screening tests Neutral $0.00 N/A
Senate Bill 1552 An Act relative to expanding the newborn screening panel Neutral $0.00 N/A
Senate Bill 1573 An Act relative to newborn screenings for congenital cytomegalovirus Neutral $0.00 N/A
House Bill 4367 An Act relative to newborn screenings for congenital cytomegalovirus Neutral $0.00 N/A
Senate Bill 2516 An Act establishing the Massachusetts data privacy act Neutral $0.00 N/A
Senate Bill 2619 An Act establishing the Massachusetts data privacy act Neutral $0.00 N/A
House Bill 4240 An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
Executive Executive Office of Labor and Workforce Development (EOLWD) Initiatives around workforce training in the life sciences industry, including but not limited to non-four-year degree pathways with hands-on experience, partnerships with minority serving Institutions, increasing career awareness in younger students, and centralizing workforce development efforts. Neutral $0.00 N/A
Executive Executive Office of Housing and Economic Development (EOHED)(Executive Office of Health and Human Services) Initiatives in the life sciences industry around workforce training, investment tax credits, economic development incentive programs, R&D Tax credits, financing and Infrastructure grants. Massachusetts Life Sciences Center initiatives around internship programs, tax incentive programs, seed funding, and capital project grants Neutral $0.00 N/A
Executive Office of the Governor Regulations or policies pertaining to drug innovation, pharmaceuticals, recycling and disposal, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, and patient access. Neutral $0.00 N/A
Executive Center for Health Information and Analysis (CHIA) 957 CMR 12,00 – Pharmacy Benefit Manager Reporting Neutral $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: Biotechnology Innovation Organization
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 1364 An Act relative to promoting healthcare access and affordability for patients Support $0.00 N/A
Senate Bill 724 An Act promoting healthcare access and affordability for patients Support $0.00 N/A
House Bill 1274 An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program Oppose $0.00 N/A
House Bill 4494 An Act prohibiting PBMs from discriminating against hospitals and patients participating in the 340B drug discount program Oppose $0.00 N/A
House Bill 1107 An Act prohibiting discrimination against 340b drug discount program participants Oppose $0.00 N/A
House Bill 4490 An Act prohibiting discrimination against 340b drug discount program participants Oppose $0.00 N/A
House Bill 1296 An Act to protect 340B providers Oppose $0.00 N/A
House Bill 4495 An Act to protect 340B providers Oppose $0.00 N/A
Senate Bill 819 An Act prohibiting discrimination against 340b drug discount program participants Oppose $0.00 N/A
Senate Bill 779 An Act to protect 340B providers Oppose $0.00 N/A
House Bill 785 An Act protecting 340B contract pharmacies Oppose $0.00 N/A
Senate Bill 845 An Act to protect 340B providers in the Medicaid program Oppose $0.00 N/A
House Bill 779 An Act to protect 340B providers in the MassHealth program Oppose $0.00 N/A
Senate Bill 868 An Act enhancing health care market oversight and pharmaceutical access Oppose $0.00 N/A
Senate Bill 848 An Act relating to covered entity reporting to increase accountability to safeguard benefit for vulnerable patients Neutral $0.00 N/A
House Bill 1082 An Act to enact the pharmacy benefit manager compensation reform Support $0.00 N/A
House Bill 1167 An Act to enact pharmacy benefit manager duties Support $0.00 N/A
House Bill 1334 An Act to enact pharmacy benefit manager duties Neutral $0.00 N/A
House Bill 1234 An Act relative to pharmacy benefit managers Support $0.00 N/A
House Bill 1324 An Act relative to prescription drug pricing Neutral $0.00 N/A
House Bill 1326 An Act to ensure access to prescription medications Neutral $0.00 N/A
House Bill 4346 An Act to ensure access to prescription medications Neutral $0.00 N/A
Senate Bill 827 An Act to ensure access to prescription medications Neutral $0.00 N/A
House Bill 1322 An Act ensuring access to specialty medications Neutral $0.00 N/A
House Bill 4497 An Act ensuring access to specialty medications Neutral $0.00 N/A
Senate Bill 734 An Act ensuring access to specialty medications Neutral $0.00 N/A
Senate Bill 694 An Act empowering health care consumers Neutral $0.00 N/A
House Bill 1325 An Act to ensure access to generic medication Neutral $0.00 N/A
Senate Bill 875 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
House Bill 1092 An Act to ensure affordable prescription medications through accountability standards Neutral $0.00 N/A
House Bill 4489 An Act to ensure affordable prescription medications through accountability standards Neutral $0.00 N/A
House Bill 1080 An Act relative to copay assistance Neutral $0.00 N/A
House Bill 4043 An Act relative to copay assistance for medications Neutral $0.00 N/A
House Bill 1101 An Act relative to consumer deductibles Support $0.00 N/A
House Bill 4333 An Act relative to consumer deductibles Support $0.00 N/A
Senate Bill 698 An Act relative to consumer deductibles Support $0.00 N/A
House Bill 1384 An Act updating the health care cost growth benchmark and associated market oversight activities Neutral $0.00 N/A
Senate Bill 1583 An Act to restore integrity in the marketing of pharmaceutical products and medical devices Neutral $0.00 N/A
Senate Bill 1584 An Act to prevent undue influence on prescriber behavior Neutral $0.00 N/A
Senate Bill 895 An Act to promote transparency and prevent price gouging of pharmaceutical drug prices Neutral $0.00 N/A
Senate Bill 884 An Act to define modest meals and refreshments in prescriber education settings Neutral $0.00 N/A
Senate Bill 2035 An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing Neutral $0.00 N/A
House Bill 2509 An Act relative to the availability of prescription medication during an emergency Neutral $0.00 N/A
Senate Bill 904 An Act to strengthen health spending accountability processes within the health policy commission and the center for health information and analysis Neutral $0.00 N/A
House Bill 1374 An Act establishing a state-wide drug repository program Neutral $0.00 N/A
House Bill 1227 An Act relative to patient access to biomarker testing to provide appropriate therapy Support $0.00 N/A
House Bill 4339 An Act relative to patient access to biomarker testing to provide appropriate therapy Support $0.00 N/A
Senate Bill 809 An Act relative to patient access to biomarker testing to provide appropriate therapy Support $0.00 N/A
House Bill 1368 An Act to provide rapid whole genome sequencing Support $0.00 N/A
Senate Bill 847 An Act relative to rapid whole genome sequencing Support $0.00 N/A
House Bill 2384 An Act relative to provider choice Support $0.00 N/A
Senate Bill 1514 An Act relative to provider choice Support $0.00 N/A
House Bill 1125 An Act relative to non-medical switching Neutral $0.00 N/A
House Bill 4491 An Act relative to non-medical switching Neutral $0.00 N/A
Senate Bill 693 An Act relative to non-medical switching Neutral $0.00 N/A
House Bill 1136 An Act improving the health insurance prior authorization process Neutral $0.00 N/A
House Bill 4616 An Act improving the health insurance prior authorization process Neutral $0.00 N/A
House Bill 4375 An Act to preserve and advance Massachusetts’ competitiveness in discovery, research, and innovation for a vibrant economy Support $0.00 N/A
House Bill 401 An Act to protect innovation and entrepreneurship in the Commonwealth Oppose $0.00 N/A
House Bill 2430 An Act including Krabbe Disease in newborn screening Neutral $0.00 N/A
Senate Bill 1530 An Act improving newborn screening tests Neutral $0.00 N/A
Senate Bill 1552 An Act relative to expanding the newborn screening panel Neutral $0.00 N/A
Senate Bill 1573 An Act relative to newborn screenings for congenital cytomegalovirus Neutral $0.00 N/A
House Bill 4367 An Act relative to newborn screenings for congenital cytomegalovirus Neutral $0.00 N/A
Senate Bill 2516 An Act establishing the Massachusetts data privacy act Neutral $0.00 N/A
Senate Bill 2619 An Act establishing the Massachusetts data privacy act Neutral $0.00 N/A
House Bill 4240 An Act making appropriations for the fiscal year 2026 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
Executive Executive Office of Labor and Workforce Development (EOLWD) Initiatives around workforce training in the life sciences industry, including but not limited to non-four-year degree pathways with hands-on experience, partnerships with minority serving Institutions, increasing career awareness in younger students, and centralizing workforce development efforts. Neutral $0.00 N/A
Executive Executive Office of Housing and Economic Development (EOHED)(Executive Office of Health and Human Services) Initiatives in the life sciences industry around workforce training, investment tax credits, economic development incentive programs, R&D Tax credits, financing and Infrastructure grants. Massachusetts Life Sciences Center initiatives around internship programs, tax incentive programs, seed funding, and capital project grants Neutral $0.00 N/A
Executive Office of the Governor Regulations or policies pertaining to drug innovation, pharmaceuticals, recycling and disposal, provider and industry practices related to pharmaceuticals, drug pricing, drug transparency, prescribing, dispensing and monitoring controlled substances and related policies, and patient access; also vaccine related issues. Neutral $0.00 N/A
Executive Center for Health Information and Analysis (CHIA) 957 CMR 12,00 – Pharmacy Benefit Manager Reporting Neutral $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: Acadia Pharmaceuticals Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 724 An Act promoting healthcare access and affordability for patients Support $0.00 N/A
House Bill 1364 An Act relative to promoting healthcare access and affordability for patients Support $0.00 N/A
Senate Bill 875 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
Senate Bill 868 An Act enhancing health care market oversight and pharmaceutical access Oppose $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: Amgen Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 724 An Act promoting healthcare access and affordability for patients Support $0.00 N/A
Senate Bill 875 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
Senate Bill 868 An Act enhancing health care market oversight and pharmaceutical access Oppose $0.00 N/A
Senate Bill 819 An Act prohibiting discrimination against 340b drug discount program participants Oppose $0.00 N/A
Senate Bill 779 An Act to protect 340B providers Oppose $0.00 N/A
Senate Bill 845 An Act to protect 340B providers in the Medicaid program Oppose $0.00 N/A
Senate Bill 848 An Act relating to covered entity reporting to increase accountability to safeguard benefit for vulnerable patients Neutral $0.00 N/A
Senate Bill 698 An Act relative to consumer deductibles Support $0.00 N/A
Senate Bill 809 An Act relative to patient access to biomarker testing to provide appropriate therapy Support $0.00 N/A
House Bill 1227 An Act relative to patient access to biomarker testing to provide appropriate therapy Support $0.00 N/A
House Bill 1101 An Act relative to consumer deductibles Support $0.00 N/A
House Bill 1234 An Act relative to pharmacy benefit managers Support $0.00 N/A
House Bill 1082 An Act to enact the pharmacy benefit manager compensation reform Support $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: NanoDx, Inc
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 231 An Act to establish an acquired brain injury advisory board Neutral $0.00 N/A
Senate Bill 134 An Act to establish an acquired brain injury advisory board Neutral $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: PTC Therapeutics
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Executive Other No lobbying activities conducted. Neutral $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: Sage Therapeutics, Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 1407 Resolve to ensure delivery of mental health services to adults with acute mental illness Support $0.00 N/A
Senate Bill 1115 An Act to provide continuum of care for severe mental illness Neutral $0.00 N/A
Senate Bill 709 An Act for supportive care for serious mental illness Neutral $0.00 N/A
Senate Bill 809 An Act relative to patient access to biomarker testing to provide appropriate therapy Neutral $0.00 N/A
House Bill 1801 An Act to provide continuum of care for severe mental illness Neutral $0.00 N/A
House Bill 2224 An Act relative to improving mental health care through innovation Neutral $0.00 N/A
House Bill 1135 An Act for supportive care for serious mental illness Neutral $0.00 N/A
House Bill 1314 An Act enhancing post-pregnancy mental health care Support $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: UCB, Inc.
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 4641 An Act relating to seizure disorders in schools. Neutral $0.00 N/A
House Bill 635 An Act relating to seizure disorders in schools Support $0.00 N/A
Senate Bill 422 An Act relating to seizure disorders in schools Support $0.00 N/A
House Bill 644 An Act updating the administration of medications in schools statute to include epilepsy Neutral $0.00 N/A
Senate Bill 724 An Act promoting healthcare access and affordability for patients Support $0.00 N/A
Senate Bill 875 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
Senate Bill 868 An Act enhancing health care market oversight and pharmaceutical access Oppose $0.00 N/A
Senate Bill 819 An Act prohibiting discrimination against 340b drug discount program participants Oppose $0.00 N/A
Senate Bill 779 An Act to protect 340B providers Oppose $0.00 N/A
Senate Bill 845 An Act to protect 340B providers in the Medicaid program Oppose $0.00 N/A
Senate Bill 848 An Act relating to covered entity reporting to increase accountability to safeguard benefit for vulnerable patients Neutral $0.00 N/A
Senate Bill 698 An Act relative to consumer deductibles Support $0.00 N/A
Senate Bill 809 An Act relative to patient access to biomarker testing to provide appropriate therapy Support $0.00 N/A
House Bill 1227 An Act relative to patient access to biomarker testing to provide appropriate therapy Support $0.00 N/A
House Bill 1101 An Act relative to consumer deductibles Support $0.00 N/A
House Bill 1234 An Act relative to pharmacy benefit managers Support $0.00 N/A
House Bill 1082 An Act to enact the pharmacy benefit manager compensation reform Support $0.00 N/A
    Total amount $0.00  
Lobbyist: John F.X. Heffernan
Client: Acuity Strategic Partners LLC
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Executive Other No lobbying activities conducted. Neutral $0.00 N/A
    Total amount $0.00  
 
Meals, Travel, and Entertainment Expenses
No meals, travel, or entertainment expenses were filed for this disclosure reporting period.
 
Additional Expenses
No additional expenses were filed for this disclosure reporting period.
 
Campaign Contributions
DateLobbyist nameRecipient nameOffice soughtAmount
07/24/2025 John F.X. Heffernan William Driscoll State Senate, Norfolk, Plymouth and Bristol $200.00
07/29/2025 John F.X. Heffernan Michael Moran State Representative, 18th Suffolk $200.00
07/31/2025 John F.X. Heffernan Kim Driscoll Lieutenant Governor, Commonwealth of Massachusetts $200.00
09/12/2025 John F.X. Heffernan Paul Feeney State Senate, Bristol and Norfolk $200.00
09/15/2025 John F.X. Heffernan Richard Haggerty State Representative, 30th Middlesex $200.00
09/18/2025 John F.X. Heffernan Sean Reid State Representative, 11th Essex $200.00
10/02/2025 John F.X. Heffernan Brendan Crighton State Senate, Third Essex $200.00
10/15/2025 John F.X. Heffernan Edward Philips State Representative, 8th Norfolk $200.00
10/16/2025 John F.X. Heffernan Dennis Gallagher State Representative, 8th Plymouth $200.00
10/21/2025 John F.X. Heffernan Rob Consalvo State Representative, 14th Suffolk $200.00
10/21/2025 John F.X. Heffernan Joanne Comerford State Senate, Hampshire, Franklin and Worcester $200.00
10/21/2025 John F.X. Heffernan Thomas Stanley State Representative, 9th Middlesex $200.00
10/21/2025 John F.X. Heffernan Kristin Kassner State Representative, 2nd Essex $200.00
10/29/2025 John F.X. Heffernan Sean Garballey State Representative, 23rd Middlesex $200.00
10/29/2025 John F.X. Heffernan James O’Day State Representative, 14th Worcester $200.00
11/08/2025 John F.X. Heffernan Sally Kerans State Representative, 13th Essex $200.00
11/11/2025 John F.X. Heffernan Committee for a Democratic Senate PAC Committee for a Democratic Senate PAC $200.00
11/12/2025 John F.X. Heffernan Daniel J. Ryan State Representative, 2nd Suffolk $200.00
11/18/2025 John F.X. Heffernan Daniel Hunt State Representative, 13th Suffolk $200.00
11/20/2025 John F.X. Heffernan Jennifer Armini State Representative, 8th Essex $200.00
12/02/2025 John F.X. Heffernan Danielle Gregoire State Representative, 4th Middlesex $200.00
12/07/2025 John F.X. Heffernan Sal DiDomenico State Senate, Middlesex and Suffolk $200.00
12/07/2025 John F.X. Heffernan John Cronin State Senate, Worcester and Middlesex $200.00
12/08/2025 John F.X. Heffernan Jacob Oliveira State Senate, Hampden, Hampshire and Worcester $200.00
12/08/2025 John F.X. Heffernan Michael Finn State Representative, 6th Hampden $200.00
12/10/2025 John F.X. Heffernan Michael Day State Representative, 31st Middlesex $200.00
   Total contributions $5,200.00
Close this page
William Francis Galvin Secretary of the Commonwealth of Massachusetts
One Ashburton Place
Boston, MA   02108

1-800-392-6090
cis@sec.state.ma.us

Connect with Us
Instagram Instagram
YouTube YouTube
Terms and Conditions     Accessibility Statement